ClinicalTrials.govpublic full text
Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients
acute myeloid leukemia (relapsed/refractory), relapsed/refractory, aml, selinexor and chidamide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840329
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.